Valuation Shenzhen YHLO Biotech Co., Ltd.
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.15 CNY | -1.50% |
|
-3.13% | +6.69% |
Company Valuation: Shenzhen YHLO Biotech Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 13,993 | 11,142 | 12,993 | 9,010 | 8,657 | 8,657 | - |
| Change | - | -20.38% | 16.62% | -30.65% | -3.93% | 0% | - |
| Enterprise Value (EV) | 13,993 | 11,142 | 12,993 | 9,010 | 8,657 | 8,657 | 8,657 |
| Change | - | -20.38% | 16.62% | -30.65% | -3.93% | 0% | 0% |
| P/E ratio | 64x | 10.9x | 36.9x | 29.8x | 27.8x | 21.8x | 19.5x |
| PBR | 9.21x | - | 5.08x | 3.27x | 3.01x | 2.69x | 2.43x |
| PEG | -9.28x | 0x | -0.6x | -2.1x | 10.52x | 0.8x | 1.6x |
| Capitalization / Revenue | 11.8x | - | 6.33x | 4.52x | 4.37x | 3.51x | 3.18x |
| EV / Revenue | 0x | - | 0x | 0x | 4.37x | 3.51x | 3.18x |
| EV / EBITDA | - | - | 0x | 0x | 12.4x | 10.5x | 8.78x |
| EV / EBIT | 0x | - | 0x | 0x | 45.3x | 16.2x | 20x |
| EV / FCF | - | - | - | -0x | 177x | 32.5x | - |
| FCF Yield | - | - | - | -0.7% | 0.57% | 3.07% | - |
| Dividend per Share 2 | 0.2857 | - | - | 0.21 | 0.1 | 0.3 | - |
| Rate of return | 1.16% | - | - | 1.33% | 0.66% | 1.98% | - |
| EPS 2 | 0.3857 | 1.8 | 0.62 | 0.53 | 0.544 | 0.694 | 0.7767 |
| Distribution rate | 74.1% | - | - | 39.6% | 18.4% | 43.2% | - |
| Net sales 1 | 1,189 | - | 2,053 | 1,992 | 1,980 | 2,464 | 2,721 |
| EBITDA 1 | - | - | 529.8 | 941.4 | 696.2 | 827.5 | 986.3 |
| EBIT 1 | 235.7 | - | 340.5 | 307.5 | 191 | 535 | 433 |
| Net income 1 | 208.6 | - | 358.4 | 301.7 | 277.9 | 420.5 | 443.4 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 24.68 | 19.65 | 22.87 | 15.80 | 15.15 | 15.15 | 15.15 |
| Nbr of stocks (in thousands) | 567,000 | 567,000 | 568,129 | 570,267 | 571,388 | 571,388 | - |
| Announcement Date | 18/02/22 | 27/02/23 | 23/02/24 | 27/02/25 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 27.85x | - | - | 0.66% | 1.24B | ||
| 81.63x | 9.63x | 57.11x | -.--% | 13.74B | ||
| 35.63x | - | - | - | 7.63B | ||
| 23.58x | 1.96x | 10.41x | 2.21% | 6.56B | ||
| 20.99x | 3.9x | 14.35x | 1.54% | 5.8B | ||
| 42.59x | 13.24x | 33.22x | 0.59% | 5.1B | ||
| 30.33x | 5.42x | 16.43x | 1.12% | 4.92B | ||
| 51.59x | 20.71x | 36.11x | 0.97% | 1.92B | ||
| Average | 39.27x | 9.15x | 27.94x | 1.01% | 5.86B | |
| Weighted average by Cap. | 46.25x | 7.93x | 33.01x | 0.88% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 688575 Stock
- Valuation Shenzhen YHLO Biotech Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















